Tonsillectomy. Indications Contraindications describe the oropharyngeal findings, explain prevention

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Loading Image
Loading Image

Tonsillectomy


Oropharyngeal Anatomy — Tonsil Bed

Anatomy of the tonsil bed — sagittal cross-section
The palatine tonsils sit within the tonsillar fossa of the oropharynx. Key relationships:
BorderStructure
SuperiorSoft palate
InferiorLingual tonsil
DeepSuperior constrictor muscle
AnteriorPalatoglossus muscle (anterior pillar)
PosteriorPalatopharyngeus muscle (posterior pillar)
Vascular supply:
  • Superior pole — ascending pharyngeal artery, lesser palatine artery
  • Inferior pole — tonsillar branches of the facial artery, dorsal lingual artery, ascending palatine artery
The inferior pole is the dominant vascular entry point; hemostatic effort directed here first controls most intraoperative bleeding.

Oropharyngeal Findings Warranting Tonsillectomy

On examination, findings that prompt surgical referral include:
  • Tonsillar hypertrophy — enlargement that narrows the oropharyngeal airway; graded on the Brodsky scale (1–4+); 3+ to 4+ tonsils significantly reduce the airway lumen
  • Asymmetric tonsil enlargement — raises concern for neoplasm (lymphoma, squamous cell carcinoma); requires biopsy
  • Tonsillar exudate / cryptic debris — recurrent or chronic purulent exudates in the crypts suggest chronic bacterial tonsillitis (mixed flora, often with beta-lactamase-producing organisms in adults)
  • Peritonsillar fullness or bulging — unilateral anterior displacement of the soft palate and tonsil with contralateral uvular deviation is classic for peritonsillar abscess
  • Tonsillar surface irregularity or ulceration — hard, irregular, ulcerated, or fixed tonsil may represent malignancy
  • Retrognathia / micrognathia or dental malocclusion — may be secondary to adenotonsillar hypertrophy causing craniofacial remodeling
Pfenninger and Fowler's Procedures for Primary Care, 3e, p. 547–549

Indications for Tonsillectomy

Absolute Indications

  1. Tonsillar hypertrophy causing obstructive sleep symptoms (children or adults) leading to adverse pulmonary or cardiovascular consequences (cor pulmonale, pulmonary hypertension)
  2. Hypertrophy with airway obstruction leading to craniofacial bone malformation or dental malocclusion
  3. Hypertrophy causing dysphagia and poor weight gain
  4. Recurrent peritonsillar abscesses requiring drainage that fail to resolve with appropriately dosed antibiotics
  5. Febrile convulsions triggered by tonsillitis episodes
  6. Suspected malignancy — suspect growth or anatomic characteristics requiring biopsy to exclude neoplasm

Relative Indications

  1. Recurrent acute tonsillitis — 3 or more documented episodes per year causing missed work/school requiring medical treatment; some clinicians use the Paradise criteria (6–7 episodes in 1 year, 5/year × 2 years, or 3/year × 3 years) particularly in children
  2. Chronic tonsillitis
  3. Obstructive sleep apnea (OSA) — adenotonsillectomy is first-line in pediatric OSA
  4. Persistent halitosis or foul taste not responding to medical therapy (tonsillar crypt disease)
  5. Streptococcal carrier state with chronic bouts unresponsive to beta-lactamase–resistant antibiotics
  6. Nocturnal enuresis with coexistent obstructive sleep disorder from adenotonsillar hypertrophy
  7. ADHD resistant to treatment with coexistent upper airway obstructive sleep disorder

Acute "Quinsy" (Hot) Tonsillectomy Indications

  • Recurrent peritonsillar abscess
  • Massive tonsils causing acute airway obstruction
  • Patient already under general anesthesia due to comfort/exposure issues
Pfenninger and Fowler's Procedures for Primary Care, 3e; K. J. Lee's Essential Otolaryngology; Cummings Otolaryngology

Contraindications

ContraindicationNotes
Poor anesthetic riskASA class IV or unstable cardiopulmonary disease
Uncontrolled systemic illnessDiabetes, cardiac failure, uncontrolled hypertension
AnemiaCorrect pre-operatively before elective surgery
Active acute bilateral tonsillitisDefer until infection resolves (increased bleeding risk)
Coagulopathy / anticoagulated patientReverse coagulopathy or anticoagulation first; consult otolaryngology
Special caution groups (not absolute contraindications, but require close monitoring):
  • Children < 3 years or with history of prematurity
  • Seizure disorders, neuromuscular conditions, or asthma
  • Severe obstructive sleep apnea (risk of post-obstructive pulmonary edema after removal of obstruction)
  • Cardiovascular defects or heart murmurs (require perioperative antibiotic prophylaxis)
Pfenninger and Fowler's Procedures for Primary Care, 3e, p. 548–549

Prevention (Post-tonsillectomy Hemorrhage Prevention)

Post-tonsillectomy hemorrhage is the primary serious complication. It occurs:
  • Primarily — intraoperatively or immediately postoperatively
  • Secondary — 5–7 days after surgery when eschar sloughs
Prevention strategies include:
  1. Antibiotic prophylaxis — intraoperative IV antibiotics (e.g., ampicillin) followed by a 1-week oral course have been shown to significantly reduce postoperative morbidity
  2. Local anesthetic injection — into the tonsillar bed at the start of surgery may decrease hemorrhage and improve postoperative recovery
  3. Directed hemostasis — controlling the superior and inferior poles first (primary vascular entry points) before addressing the tonsillar bed at large
  4. Surgical technique — gentle, careful removal of all tonsillar tissue reduces postoperative pain and recovery time; complete removal reduces risk of bleeding and recurrence (especially in intracapsular procedures)
  5. Pre-operative workup — CBC, PT/INR, and bleeding time when there is any suspicion of a bleeding disorder
  6. Avoid loose deciduous teeth — evaluate and remove extremely loose teeth that could be dislodged and threaten the airway intraoperatively

Types of Tonsillectomy and Prevention Implications

Extracapsular vs intracapsular tonsillectomy
  • Extracapsular (subcapsular) — removes tonsil and capsule entirely; pharyngeal muscles left to re-epithelialize; currently the favored technique
  • Intracapsular (tonsillotomy) — removes tonsillar body only, capsule remains; theoretically less pain and faster recovery, but leaves residual tissue with risk of recurrence and bleeding if all tonsillar tissue is not removed
Pfenninger and Fowler's Procedures for Primary Care, 3e, p. 549–550; Cummings Otolaryngology Head and Neck Surgery

Give me more detailed information

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Finding Sources
The response above covers the full detail across all four domains. Here is a brief orientation to what was added beyond the previous summary:
Oropharyngeal findings — expanded with the Brodsky grading scale image (0 to +4, measured as percentage of oropharyngeal width occupied), craniofacial sequelae of chronic obstruction, microbiology of adult tonsils, and detailed clinical signs distinguishing chronic tonsillitis from peritonsillar abscess from suspected malignancy.
Indications — added frequency thresholds table (Paradise-based), detailed OSA/OSAS pathophysiology through to cor pulmonale, STOP-BANG and STBUR screening tools, cardiac endocarditis as an absolute indication, and specific peritonsillar abscess timing (acute "quinsy" vs. delayed interval tonsillectomy).
Contraindications — expanded with OSA-specific admission thresholds (AAO-HNS: AHI ≥ 10 or SpO₂ < 80%; AAP: AHI ≥ 24 or EtCO₂ ≥ 60 mmHg), and a detailed high-risk groups table with rationale for each.
Prevention — stratified into pre-operative, intraoperative, and post-operative phases; added the "six hours or six days" hemorrhage guideline, full analgesic safety data (codeine FDA contraindication, ketorolac contraindication, NSAIDs safety, ondansetron dosing), post-operative antibiotic evidence summary (Cochrane: no benefit beyond fever reduction), and OSA cure rate evidence table from major trials.
This is a shared conversation. Sign in to Orris to start your own chat.